Cancer Network speaks with Joseph Unger, PhD, about ways to decrease the barriers for cancer patients to enroll in clinical trials.
Joseph Unger, PhD, MS
Advertisement
Articles by Joseph Unger, PhD, MS
Advertisement
Latest Updated Articles
Decreasing Clinical Trial Participation BarriersPublished: February 20th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
2
Tarlatamab Improves Survival Vs Chemotherapy in Second-Line SCLC Subgroups
3
Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC
4
Frontline Alectinib Upholds OS Benefit in Advanced ALK+ NSCLC
5
